Report - STATISTICAL ANALYSIS PLAN PHASE 3 - ClinicalTrials.gov · 2018. 9. 11. · Neurocrine Biosciences, Inc. NBI-98854-1402 Statistical Analysis Plan 1 STATISTICAL ANALYSIS PLAN PHASE

Please pass captcha verification before submit form